ArticleIndian dermatology online journal2026
Study of Clinico-demography and Impact on Quality of Life of Patients with Scalp Pruritus.
Article in Indian dermatology online journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundScalp pruritus is a common symptom in both dermatologic and nondermatologic conditions. Despite its prevalence, its clinico-demography and impact on quality of life (QoL) remain underexplored. AIM AND
objectivesThis study aims to analyze the clinico-demography of scalp pruritus and its effect on the QoL of patients attending the dermatology department at a tertiary care institute. PATIENTS AND
methodsAn observational cross-sectional study was conducted over 18 months (July 2022 to January 2024). The sample size was 500, and patients were selected from the dermatology outpatient department. Demographics, etiology, pruritus severity (Visual Analog Scale), and QoL (using Dermatology Life Quality Index) were assessed.
resultsThe most common dermatological causes were seborrheic dermatitis (45.4%) and psoriasis (10.6%). Non-dermatologic causes included diabetes mellitus (8.2%) and post-herpetic neuralgia (5.4%). Moderate to very severe pruritus was reported by 54.6% of patients. A small effect on QoL was reported by 37.4% patients, and an extremely large effect by 12.8%. LIMITATIONS: The study was single-centered and relied on subjective assessments. Confounding factors like comorbidities and medications were not fully explored.
conclusionScalp pruritus significantly impacts patients' QoL. A multidisciplinary approach addressing both dermatologic and systemic causes is essential for effective management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.